Cite
Tolerance and feasibility of chemotherapy by procarbazine, lomustine, and vincristine (PCV) for oligodendroglial anaplastic gliomas (OAG)
MLA
Marie Wertz, et al. “Tolerance and Feasibility of Chemotherapy by Procarbazine, Lomustine, and Vincristine (PCV) for Oligodendroglial Anaplastic Gliomas (OAG).” Journal of Clinical Oncology, vol. 30, May 2012, p. 2060. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........9199912d690a2a62f8a1eee714218d7b&authtype=sso&custid=ns315887.
APA
Marie Wertz, Maryline Barrie, Dominique Figarella, Celine Boucard, Stéphane Honoré, Emeline Tabouret, Mona Matta, Didier Autran, Marine Daros, & O. L. Chinot. (2012). Tolerance and feasibility of chemotherapy by procarbazine, lomustine, and vincristine (PCV) for oligodendroglial anaplastic gliomas (OAG). Journal of Clinical Oncology, 30, 2060.
Chicago
Marie Wertz, Maryline Barrie, Dominique Figarella, Celine Boucard, Stéphane Honoré, Emeline Tabouret, Mona Matta, Didier Autran, Marine Daros, and O. L. Chinot. 2012. “Tolerance and Feasibility of Chemotherapy by Procarbazine, Lomustine, and Vincristine (PCV) for Oligodendroglial Anaplastic Gliomas (OAG).” Journal of Clinical Oncology 30 (May): 2060. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........9199912d690a2a62f8a1eee714218d7b&authtype=sso&custid=ns315887.